All Dr Rachel Shi (Principal Scientist - Bioanalytical Mass Spectrometry Group - Genentech) articles
-
ArticleMass spectrometry workflows powering the future of biologics
Analysing complex biologics is one of drug discovery’s biggest challenges. At Genentech, Rachel Shi is developing MS workflows that deliver clearer answers, faster.